SCHEMBL1070844

SCHEMBL1070844

CCCCOC(=O)C(=O)OCCC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.61
ATM Q13315 1/20 0.56
TSHR P16473 5/20 0.54
HPGD P15428 1/20 0.52
HCAR2 Q8TDS4 1/20 0.48
NAAA Q02083 1/20 0.48
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
RAD52 P43351 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
EPHX1 P07099 1/20 0.45
LMNA P02545 1/20 0.44
ESR1 P03372 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
MAPK1 P28482 1/20 0.44
CYP2C19 P33261 1/20 0.44
NR1H2 P55055 1/20 0.44
RNASEL Q05823 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL137155 0.95 ALDH1A1 (0.67) ALDH1A1ATMTSHRHPGDHCAR2
SCHEMBL5501929 0.95 ALDH1A1 (0.67) ALDH1A1ATMTSHRHPGDHCAR2
SCHEMBL28787473 0.95 ALDH1A1 (0.67) ALDH1A1ATMTSHRHPGDHCAR2
SCHEMBL3761732 0.92 TSHR (0.63) ALDH1A1ATMTSHRHCAR2NAAA
SCHEMBL5501926 0.92 ALDH1A1 (0.64) ALDH1A1ATMTSHRHPGDHCAR2
SCHEMBL28131973 0.92 ALDH1A1 (0.64) ALDH1A1ATMTSHRHPGDHCAR2
Fluoride SCHEMBL3958324 0.92 ALDH1A1 (0.64) ALDH1A1ATMTSHRHPGDHCAR2
SCHEMBL185252 0.90 TSHR (0.67) ALDH1A1TSHRHCAR2NAAARAD52
SCHEMBL1979194 0.90 TSHR (0.65) ALDH1A1ATMTSHRHPGDHCAR2
SCHEMBL138475 0.89 HCAR2 (0.48) ALDH1A1ATMTSHRHPGDHCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2943072-B2 METHODS FOR AFFECTING THE FLAVOUR AND AROMA PROFILE OF CONSUMABLES IMPOSSIBLE FOODS INC (US) 2025-04-30 EP disclosed
CN-118663266-A Indium-copper bimetallic/SiO2-ZrO2Catalyst, preparation method thereof and method for preparing ethylene glycol by using catalyst 高化学株式会社 2024-09-20 CN disclosed
US-20240298680-A1 METHODS AND COMPOSITIONS FOR CONSUMABLES IMPOSSIBLE FOODS INC. 2024-09-12 US disclosed
US-20240298681-A1 METHODS AND COMPOSITIONS FOR AFFECTING THE FLAVOR AND AROMA PROFILE OF CONSUMABLES IMPOSSIBLE FOODS INC. 2024-09-12 US disclosed
CN-118510877-A Cleaning composition for pretreatment of metal substrates, method for the production thereof and use thereof 巴斯夫涂料有限公司 2024-08-16 CN disclosed
WO-2023131530-A1 A CLEANING COMPOSITION FOR METAL SUBSTRATES PRETREATMENT AND ITS PREPARATION METHOD AND APPLICATION THEREOF BASF COATINGS GMBH (DE) 2023-07-13 WO disclosed
EP-4104682-A2 METHODS AND COMPOSITIONS FOR AFFECTING THE FLAVOUR AND AROMA PROFILE OF CONSUMABLES Impossible Foods Inc. (US) 2022-12-21 EP disclosed
EP-3345484-B1 MEAT SUBSTITUTE AND METHOD FOR IMPARTING A BEEF-LIKE FLAVOUR TO A MEAT SUBSTITUTE IMPOSSIBLE FOODS INC (US) 2022-08-10 EP disclosed
WO-2022041218-A1 COPPER-BASED CATALYST AND PREPARATION METHOD THEREFOR 高化学株式会社 2022-03-03 WO disclosed
US-20220061365-A1 METHODS AND COMPOSITIONS FOR CONSUMABLES IMPOSSIBLE FOODS INC. 2022-03-03 US disclosed
US-6525059-B1 Mitogen-activated protein kinases (MAP); G. D. SEARLE & COMPANY 2003-02-25 US disclosed
US-20030021853-A1 In situ mono-or diester dicarboxylate compositions ECOLAB USA INC. 2003-01-30 US disclosed
WO-2003005817-A2 HIGH CONCENTRATION MONOESTER PEROXY DICARBOXYLIC ACID COMPOSITIONS, USE SOLUTIONS, AND METHODS EMPLOYING THEM ECOLAB INC. (US) 2003-01-23 WO disclosed
WO-2003005818-A1 IN SITUMONO-OR DIESTER DICARBOXYLATE COMPOSITIONS ECOLAB INC. (US) 2003-01-23 WO disclosed
US-20020168422-A1 Two solvent antimicrobial compositions and methods employing them ECOLAB USA INC. 2002-11-14 US disclosed
US-5691321-A INSECTICIDES, MITICIDES, PARASITICIDES HOECHST SCHERING AGREVO GMBH (DE) 1997-11-25 US disclosed
US-4873263-A ESTER PRODRUG DERIVATIVES MERCK & CO., INC. (US) 1989-10-10 US disclosed
EP-0287341-A1 Rectally absorbable form of L-dopa MERCK & CO. INC. (US) 1988-10-19 EP disclosed
US-4771073-A ESTER PRODRUG DERIVATIVES OF L-DOPA, OPTIONALLY WITH A DECARBOXYLASE INHIBITOR MERCK & CO., INC. (US) 1988-09-13 US disclosed
EP-0047516-A1 Propylamine derivative and process of manufacturing the same TORAY INDUSTRIES, INC. (JP) 1982-03-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030021853-A1 In situ mono-or diester dicarboxylate compositions DDC, HCAR3, ACMSD ALDH1A1 590/4885ATM 4584/4885TSHR 4231/4885
US-20020168422-A1 Two solvent antimicrobial compositions and methods employing them TAS2R50, HDHD5, CEL ALDH1A1 2741/4885ATM 3876/4885TSHR 4520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.